Softbank Vision Fund (aiv M1) L.P.
10% Owner
Softbank Vision Fund (aiv M1) L.P.10% Owner
Softbank Vision Fund (aiv M1) L.P. insider trades: Vir Biotechnology (VIR) stock buys and sales
10% Owner, Vir Biotechnology Last trade Dec 1, 2025 74 Form 4 filings
$5.3M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
71
Open-market trades
since 2019
5
Companies
last trade 2025
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Softbank Vision Fund (aiv M1) L.P. reports to the SEC
VIRVir Biotechnology
10% Owner · last filing Dec 3, 2025
-$187.5M
+$19.0M
COMPCompass
10% Owner · last filing Mar 26, 2025
-$405.8M
+$72.0M
ZYZymergen
10% Owner · last filing Oct 21, 2022
No market trades
OPENOpendoor Technologies
10% Owner · last filing Sep 20, 2021
-$537.4M
GHGuardant Health
10% Owner · last filing Oct 13, 2020
-$1.83B
+$20.0M
Open-market buys and sales
71 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | VIR | ↓ Sell | 191,854 | $5.98 | $1.1M | Indirect | Dec 3, 2025 (2d) |
| Nov 28, 2025 | VIR | ↓ Sell | 189,431 | $6.41 | $1.2M | Indirect | Dec 1, 2025 (3d) |
| Nov 25, 2025 | VIR | ↓ Sell | 463,774 | $6.27 | $2.9M | Indirect | Nov 26, 2025 (1d) |
| Oct 29, 2025 | VIR | ↓ Sell | 24,553 | $6.50 | $160K | Indirect | Oct 30, 2025 (1d) |
| Oct 27, 2025 | VIR | ↓ Sell | 113,099 | $6.01 | $680K | Indirect | Oct 28, 2025 (1d) |
| Oct 23, 2025 | VIR | ↓ Sell | 298,649 | $6.07 | $1.8M | Indirect | Oct 24, 2025 (1d) |
| Oct 21, 2025 | VIR | ↓ Sell | 330,210 | $6.23 | $2.1M | Indirect | Oct 22, 2025 (1d) |
| Oct 16, 2025 | VIR | ↓ Sell | 29,515 | $6.08 | $180K | Indirect | Oct 17, 2025 (1d) |
| Oct 10, 2025 | VIR | ↓ Sell | 251,360 | $6.14 | $1.5M | Indirect | Oct 14, 2025 (4d) |
| Oct 8, 2025 | VIR | ↓ Sell | 538,375 | $5.99 | $3.2M | Indirect | Oct 9, 2025 (1d) |
| Oct 6, 2025 | VIR | ↓ Sell | 524,297 | $5.57 | $2.9M | Indirect | Oct 7, 2025 (1d) |
| Mar 24, 2025 | COMP | ↓ Sell | 10,000,000 | $9.15 | $91.5M | Indirect | Mar 26, 2025 (2d) |
| Dec 17, 2024 | COMP | ↓ Sell | 10,000,000 | $6.33 | $63.3M | Indirect | Dec 19, 2024 (2d) |
| Sep 13, 2024 | COMP | ↓ Sell | 7,500,000 | $6.24 | $46.8M | Indirect | Sep 17, 2024 (4d) |
| May 16, 2024 | COMP | ↓ Sell | 16,900,000 | $4.30 | $72.7M | Indirect | May 20, 2024 (4d) |
| Jan 9, 2024 | COMP | ↓ Sell | 10,000,000 | $3.66 | $36.6M | Indirect | Jan 11, 2024 (2d) |
| Dec 14, 2023 | COMP | ↓ Sell | 14,895,000 | $2.66 | $39.6M | Indirect | Dec 18, 2023 (4d) |
| Jun 30, 2023 | VIR | ↓ Sell | 700 | $25.11 | $18K | Indirect | Jul 5, 2023 (5d) |
| Jun 29, 2023 | VIR | ↓ Sell | 96,952 | $25.17 | $2.4M | Indirect | Jun 30, 2023 (1d) |
| Jun 20, 2023 | VIR | ↓ Sell | 9,902 | $25.18 | $249K | Indirect | Jun 22, 2023 (2d) |
| Jun 16, 2023 | VIR | ↓ Sell | 183,326 | $25.56 | $4.7M | Indirect | Jun 20, 2023 (4d) |
| Jun 14, 2023 | VIR | ↓ Sell | 164,102 | $26.75 | $4.4M | Indirect | Jun 15, 2023 (1d) |
| Jun 7, 2023 | COMP | ↓ Sell | 15,000,000 | $3.69 | $55.4M | Indirect | Jun 9, 2023 (2d) |
| Jun 5, 2023 | VIR | ↓ Sell | 39,562 | $27.32 | $1.1M | Indirect | Jun 6, 2023 (1d) |
| May 24, 2023 | VIR | ↓ Sell | 274,451 | $26.46 | $7.3M | Indirect | May 25, 2023 (1d) |
| May 22, 2023 | VIR | ↓ Sell | 183,547 | $25.55 | $4.7M | Indirect | May 23, 2023 (1d) |
| May 5, 2023 | VIR | ↓ Sell | 136 | $25.10 | $3K | Indirect | May 9, 2023 (4d) |
| May 4, 2023 | VIR | ↓ Sell | 198,006 | $25.53 | $5.1M | Indirect | May 5, 2023 (1d) |
| May 1, 2023 | VIR | ↓ Sell | 3,075 | $25.30 | $78K | Indirect | May 3, 2023 (2d) |
| Apr 25, 2023 | VIR | ↓ Sell | 66,999 | $25.42 | $1.7M | Indirect | Apr 26, 2023 (1d) |
| Apr 21, 2023 | VIR | ↓ Sell | 311,983 | $25.76 | $8.0M | Indirect | Apr 24, 2023 (3d) |
| Apr 19, 2023 | VIR | ↓ Sell | 83,067 | $25.12 | $2.1M | Indirect | Apr 20, 2023 (1d) |
| Apr 17, 2023 | VIR | ↓ Sell | 20,089 | $25.08 | $504K | Indirect | Apr 18, 2023 (1d) |
| Feb 21, 2023 | VIR | ↓ Sell | 74,477 | $28.43 | $2.1M | Indirect | Feb 23, 2023 (2d) |
| Feb 15, 2023 | VIR | ↓ Sell | 38,964 | $26.75 | $1.0M | Indirect | Feb 17, 2023 (2d) |
| Feb 14, 2023 | VIR | ↓ Sell | 117,957 | $26.28 | $3.1M | Indirect | Feb 15, 2023 (1d) |
| Feb 10, 2023 | VIR | ↓ Sell | 234,271 | $26.28 | $6.2M | Indirect | Feb 13, 2023 (3d) |
| Feb 8, 2023 | VIR | ↓ Sell | 145,422 | $28.51 | $4.1M | Indirect | Feb 9, 2023 (1d) |
| Feb 6, 2023 | VIR | ↓ Sell | 114,035 | $30.21 | $3.4M | Indirect | Feb 7, 2023 (1d) |
| Feb 2, 2023 | VIR | ↓ Sell | 148,635 | $29.42 | $4.4M | Indirect | Feb 3, 2023 (1d) |
| Jan 31, 2023 | VIR | ↓ Sell | 152,813 | $29.46 | $4.5M | Indirect | Feb 1, 2023 (1d) |
| Jan 23, 2023 | VIR | ↓ Sell | 36,512 | $28.34 | $1.0M | Indirect | Jan 25, 2023 (2d) |
| Jan 20, 2023 | VIR | ↓ Sell | 214,197 | $27.13 | $5.8M | Indirect | Jan 23, 2023 (3d) |
| Jan 18, 2023 | VIR | ↓ Sell | 190,839 | $26.28 | $5.0M | Indirect | Jan 19, 2023 (1d) |
| Jan 13, 2023 | VIR | ↓ Sell | 211,678 | $26.58 | $5.6M | Indirect | Jan 17, 2023 (4d) |
| Jan 11, 2023 | VIR | ↓ Sell | 149,640 | $26.32 | $3.9M | Indirect | Jan 12, 2023 (1d) |
| Jan 9, 2023 | VIR | ↓ Sell | 100,980 | $26.03 | $2.6M | Indirect | Jan 10, 2023 (1d) |
| Jan 4, 2023 | VIR | ↓ Sell | 9,177 | $25.57 | $235K | Indirect | Jan 5, 2023 (1d) |
| Dec 29, 2022 | VIR | ↓ Sell | 44,169 | $25.55 | $1.1M | Indirect | Jan 3, 2023 (5d) |
| Dec 27, 2022 | VIR | ↓ Sell | 6,850 | $25.59 | $175K | Indirect | Dec 29, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VIR insiders
Open-market trades in the last 12 months
Verneuil Vanina de
EVP, General Counsel, Corp Sec
2 sales
Nov 3, 2026
Brent Sabatini
SVP, Chief Accounting Officer
4 sales
Jun 1, 2026
Janet Napolitano
Director
1 sale
Jun 1, 2026
Vicki L Sato
Director
6 sales
May 1, 2026
Backer Marianne De
President and CEO
2 sales
Apr 6, 2026
Mark Eisner
EVP and Chief Medical Officer
1 sale
Feb 23, 2026
Jason O'Byrne
EVP & Chief Financial Officer
2 sales
Feb 23, 2026
Sb Investment Advisers (uk) Ltd
10% Owner
3 sales
Dec 1, 2025
About Softbank Vision Fund (aiv M1) L.P.'s insider trades
Softbank Vision Fund (aiv M1) L.P. is a 10% owner of Vir Biotechnology (VIR). Since Mar 12, 2019, it has reported 3 open-market purchases worth $111.0M and 68 sales worth $2.96B on SEC Form 4. In the last 12 months: 3 sales ($5.3M).
Its filings also include conversions (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VIR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.